Banc of California Reports Mixed Q1 Results with NIM Expansion and Increased Credit Quality Concerns
BANC sits 41% above its 52-week low of $12.98.
Summary
Banc of California reported first-quarter 2026 results showing year-over-year EPS growth and NIM expansion, but also a quarter-over-quarter earnings decline and a concerning rise in delinquent and nonperforming loans.
Key Events · Earnings and Guidance · BANC
-
Q1 2026 Diluted EPS
Reported diluted EPS of $0.39, representing a 50% increase year-over-year but a decline from $0.42 in the fourth quarter of 2025.
-
Net Interest Margin Expansion
Net Interest Margin (NIM) expanded by 4 basis points quarter-over-quarter to 3.24%.
-
Deterioration in Credit Quality
Delinquent loans increased by $144.1 million to $345.1 million, and nonperforming loans rose by $26.5 million to $185.7 million quarter-over-quarter. Net charge-offs significantly increased to $13.8 million from $2.7 million in the prior quarter.
-
Share Repurchase Activity
The company repurchased $31.9 million of common stock at a weighted average price of $18.68 per share during the quarter, with $82.6 million remaining under the current authorization.
Analysis · BANC · Finance
Banc of California's first-quarter 2026 results present a mixed picture for investors. While the company achieved significant year-over-year diluted EPS growth and expanded its net interest margin, quarter-over-quarter earnings declined. More critically, the filing reveals a notable increase in delinquent and nonperforming loans, alongside higher net charge-offs, signaling potential deterioration in credit quality. The company's proactive capital management, including a substantial share repurchase and plans to redeem subordinated debt, provides some offset, demonstrating financial flexibility. Investors should monitor future credit quality trends closely, as these could impact profitability despite positive NIM expansion.
At the time of this filing, BANC was trading at $18.30 on NYSE in the Finance sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $12.98 to $21.61. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.